Regulatorische Updates
2. Sept. 2026•1 Min. Lesezeit
Daewoong Pharma dispute over block‑type hub wholesale escalates
Conflict over Daewoong Pharmaceutical’s block‑type hub wholesale is set to intensify after the Fair Trade Commission dismissed the Korean Pharmaceutical Distribution Association’s complaint, prompting a planned re‑submission and a push for a parliamentary audit.
Regulatorische Updates
30. Aug. 2026•1 Min. Lesezeit
MFDS Announces Draft Rules for Cosmetics Safety Assessment, Open for Comment
South Korea's MFDS released a draft amendment to the Cosmetic Act enforcement decree and rules on July 8, seeking comments until Aug 18 to detail the new safety assessment system.